https://patholines.org/index.php?action=history&feed=atom&title=Template%3AMyoepithelial_marker_note
Template:Myoepithelial marker note - Revision history
2026-08-20T16:17:56Z
Revision history for this page on the wiki
MediaWiki 1.44.2
https://patholines.org/index.php?title=Template:Myoepithelial_marker_note&diff=7191&oldid=prev
Mikael Häggström: Expanded
2025-06-02T18:34:24Z
<p>Expanded</p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="en">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 14:34, 2 June 2025</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1">Line 1:</td>
<td colspan="2" class="diff-lineno">Line 1:</td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><ref group=note>For myoepithelial markers, a combination of p63 with either SMM or calponin is generally recommended for breast lesions. D2-40 is useful for highlighting lymphatics for invasion.</ref><noinclude>{{Bottom}}</noinclude></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ref group=note>For myoepithelial markers, a combination of <ins style="font-weight: bold; text-decoration: none;">'''</ins>p63<ins style="font-weight: bold; text-decoration: none;">''' (higher specificity) </ins>with either <ins style="font-weight: bold; text-decoration: none;">'''</ins>SMM<ins style="font-weight: bold; text-decoration: none;">''' </ins>or <ins style="font-weight: bold; text-decoration: none;">'''</ins>calponin<ins style="font-weight: bold; text-decoration: none;">''' (both have higher sensitivity) </ins>is generally recommended for breast lesions. D2-40 is useful for highlighting lymphatics for invasion.</ref><noinclude>{{Bottom}}</noinclude></div></td></tr>
</table>
Mikael Häggström
https://patholines.org/index.php?title=Template:Myoepithelial_marker_note&diff=7190&oldid=prev
Mikael Häggström: Or
2025-06-02T18:31:00Z
<p>Or</p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="en">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 14:31, 2 June 2025</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1">Line 1:</td>
<td colspan="2" class="diff-lineno">Line 1:</td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><ref group=note>For myoepithelial markers, a combination of p63 <del style="font-weight: bold; text-decoration: none;">and </del>calponin is generally recommended for breast lesions. D2-40 is useful for highlighting lymphatics for invasion.</ref><noinclude>{{Bottom}}</noinclude></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ref group=note>For myoepithelial markers, a combination of p63 <ins style="font-weight: bold; text-decoration: none;">with either SMM or </ins>calponin is generally recommended for breast lesions. D2-40 is useful for highlighting lymphatics for invasion.</ref><noinclude>{{Bottom}}</noinclude></div></td></tr>
</table>
Mikael Häggström
https://patholines.org/index.php?title=Template:Myoepithelial_marker_note&diff=5768&oldid=prev
Mikael Häggström: note
2022-06-21T18:12:10Z
<p>note</p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="en">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 14:12, 21 June 2022</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1">Line 1:</td>
<td colspan="2" class="diff-lineno">Line 1:</td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><ref group=<del style="font-weight: bold; text-decoration: none;">notes</del>>For myoepithelial markers, a combination of p63 and calponin is generally recommended for breast lesions. D2-40 is useful for highlighting lymphatics for invasion.</ref><noinclude>{{Bottom}}</noinclude></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ref group=<ins style="font-weight: bold; text-decoration: none;">note</ins>>For myoepithelial markers, a combination of p63 and calponin is generally recommended for breast lesions. D2-40 is useful for highlighting lymphatics for invasion.</ref><noinclude>{{Bottom}}</noinclude></div></td></tr>
</table>
Mikael Häggström
https://patholines.org/index.php?title=Template:Myoepithelial_marker_note&diff=4819&oldid=prev
Mikael Häggström: Noinclude
2022-02-10T13:58:46Z
<p>Noinclude</p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="en">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 09:58, 10 February 2022</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1">Line 1:</td>
<td colspan="2" class="diff-lineno">Line 1:</td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><ref group=notes>For myoepithelial markers, a combination of p63 and calponin is generally recommended for breast lesions. D2-40 is useful for highlighting lymphatics for invasion.</ref></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ref group=notes>For myoepithelial markers, a combination of p63 and calponin is generally recommended for breast lesions. D2-40 is useful for highlighting lymphatics for invasion.</ref<ins style="font-weight: bold; text-decoration: none;">><noinclude>{{Bottom}}</noinclude</ins>></div></td></tr>
</table>
Mikael Häggström
https://patholines.org/index.php?title=Template:Myoepithelial_marker_note&diff=4816&oldid=prev
Mikael Häggström: Note
2022-02-10T13:55:47Z
<p>Note</p>
<p><b>New page</b></p><div><ref group=notes>For myoepithelial markers, a combination of p63 and calponin is generally recommended for breast lesions. D2-40 is useful for highlighting lymphatics for invasion.</ref></div>
Mikael Häggström